Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EQ stock hub

Equillium, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EQis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
133.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
EQ
In the news

Latest news · EQ

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-94
P25 -105.6P50 -46.5P75 -3.1
ROIC-60.6
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001746466
Company name
Equillium, Inc.
Country
United States
Country code
US
Cusip
29446K106
Employees
35
Employees Change
-9%
Employees Change Percent
-20.45
Enterprise value
$103.9M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2018-10-11
Isin
US29446K1060
Last refreshed
2026-05-10
Market cap
$133.4M
Market cap category
Micro-Cap
Price
$2.11
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
EQ
Website
https://www.equilliumbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-16.79%
FCF yield
-17.09%
P/B ratio
4.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
$-22.4M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Profit Per Employee
$-639,943
ROA
-51.39
Roa5y
-27.29
ROCE
-81.63
ROE
-93.99
Roe5y
-73.15
ROIC
-60.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
442.91%
Cagr3y
58.47%
Cagr5y
-18.94%
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$31.9M
Cash
$30.3M
Current Assets
$31M
Current Liabilities
$2.9M
Debt
$719,000
Debt Equity
$0.03
Equity
$28.6M
Liabilities
$3.3M
Long Term Assets
$849,000
Long Term Liabilities
$356,000
Net Cash
$29.6M
Net Cash By Market Cap
$22.16
Net Cash Growth
33.2%
Net Debt Equity
$-1.03
Tangible Book Value
$28.6M
Tangible Book Value Per Share
$0.47
WACC
13.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
10.58
Net Working Capital
$-1.8M
Quick ratio
10.36
Working Capital
$28.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-62.07%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
442.28%
200-day SMA
1.48
3Y total return
298.11%
50-day SMA
2.02
50-day SMA vs 200-day SMA
50over200
5Y total return
-65.01%
All Time High
27.05
All Time High Change
-92.2%
All Time High Date
2020-07-13
All Time Low
0.27
All Time Low Change
681.48%
All Time Low Date
2025-06-24
ATR
0.18
Beta
1.67
Beta1y
-1.79
Beta2y
-0.32
Ch YTD
36.13
High
2.27
High52
2.7
High52 Date
2026-03-16
High52ch
-21.85%
Low
2.1
Low52
0.27
Low52 Date
2025-06-24
Low52ch
681.48%
Ma50ch
4.71%
Premarket Change Percent
1.4
Premarket Price
$2.17
Premarket Volume
192
Price vs 200-day SMA
43.05%
RSI
53.13
RSI Monthly
59.83
RSI Weekly
60.37
Sharpe ratio
1.68x
Sortino ratio
4.1
Total Return
-62.07%
Tr YTD
36.13
Tr1m
9.9%
Tr1w
1.44%
Tr3m
38.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
3
Analyst Count Top
1
Analyst Price Target Top
$6
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.04
Operating Income
$-23.6M
Price target
$8
Price Target Change
$279
Price Target Change Top
$184

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
31,498,337%
Float Percent
49.82%
Shares Insiders
10.85%
Shares Institutions
33.85%
Shares Out
63,226,556
Shares Qo Q
40.66%
Shares Yo Y
62.07%
Short Float
8.77%
Short Ratio
6.26
Short Shares
4.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-25.1M
Average Volume
338,529.95x
Bv Per Share
0.47
CAPEX
$-48,000
Ch1m
9.9
Ch1w
1.44
Ch1y
442.3
Ch3m
38.82
Ch3y
298.1
Ch5y
-65.01
Ch6m
91.82
Change
-1.4%
Change From Open
-1.86
Close
2.14
Days Gap
0.47
Depreciation Amortization
116,000
Dollar Volume
506,231.2
Earnings Date
2026-05-25
Earnings Time
amc
EBIT
$-23.6M
EBITDA
$-23.5M
EPS
$-0.39
F Score
1
FCF
$-22.8M
FCF EV Yield
-21.95x
FCF Per Share
$-0.36
Financing CF
30,427,000
Fiscal Year End
December
Founded
2,017
Investing CF
4,464,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-25
Ma150
1.54
Ma150ch
37.46%
Ma20
2.07
Ma20ch
1.93%
Net CF
12,192,000
Next Earnings Date
2026-05-25
Open
2.15
Optionable
Yes
Position In Range
5.88
Post Close
2.11
Postmarket Change Percent
5.94
Postmarket Price
$2.24
Ppne
822,000
Pre Close
2.14
Price Date
2026-05-08
Ptbv Ratio
4.67
Relative Volume
0.71x
Share Based Comp
2,322,000
Tr6m
91.82%
Us State
California
Volume
239,920
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EQ pay a dividend?

Capital-return profile for this ticker.

Performance

EQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+442.3%
S&P 500 1Y: n/a
3Y total return
+298.1%
S&P 500 3Y: n/a
5Y total return
-65.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns EQ?

Insider, institutional, and short-interest positioning.

Institutional ownership
+33.9%
Float: +49.8% of shares outstanding
Insider ownership
+10.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+8.8%
6.3 days to cover
Y/Y dilution
+62.1%
Negative means the company is buying back shares.
Technical

EQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
+43.1%
50/200-day relationship not available
Beta (5Y)
1.67
More volatile than the market
Sharpe ratio
1.68
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EQ stock rating?

Equillium, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EQ analysis?

The full report lives at /stocks/EQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EQ?

The latest report frames EQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.